Prenosis Sponsored Webinar: Sepsis Detection in Acute Care: How Biomarkers and AI Assist in Diagnosis and Prediction of Adverse Outcomes
Includes a Live Web Event on 04/09/2025 at 11:00 AM (PDT)
Webinar Description:
Join Prenosis during this sponsored webinar to explore the impact of AI-driven diagnostics in acute care settings. Learn how FDA-authorized Sepsis ImmunoScore™ enhances traditional early warning systems by using individuals’ biology to identify patients at highest risk for sepsis, or progression to sepsis in 24 hours. Our clinical experts will discuss:
- The role of advanced biomarker analysis in improving sepsis detection and diagnosis;
- How providers can leverage AI-based technology to complement existing early warning systems and clinical decision support;
- The importance of deploying EMR-agnostic tools that integrate in existing clinical workflow;
- Use case examples illustrating the use of multi-band tests to indicate risk levels.
This sponsored webinar is ideal for healthcare professionals interested in advancing their approach to sepsis detection and management through AI-based diagnostic technology.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Prenosis for this sponsored webinar.
Robin Carver, RN, MSN, CIC
Vice President, Health System Management
Prenosis, Inc.
Robin Carver, RN, MSN, CIC, is a dynamic healthcare executive who bridges clinical care and healthcare technology, bringing over 25 years of experience in the fields of infection prevention, clinical education, and healthcare IT. Currently serving as Vice President of Health System Engagement at Prenosis, she combines her bedside nursing background with her mastery of strategic leadership to drive commercial growth and innovation in precision medicine.
As Director of Infection Prevention at WakeMed, Robin spearheaded initiatives that reduced central line infections by 87% and eliminated ventilator-associated pneumonia in the Medical ICU. Her subsequent work as VP of Member Engagement at Premier helped over 1,300 hospitals demonstrate the tangible impact of data-driven healthcare solutions and improved patient outcomes while optimizing operational efficiency.
Beyond her corporate role, Robin remains deeply committed to her local community, where she draws on her nursing expertise to help individuals and families navigate the complexities of the healthcare system. A passionate advocate for healthcare innovation, Robin combines deep clinical expertise with business acumen to help healthcare organizations navigate the evolving landscape of AI-enabled care delivery. She holds an MSN in Nursing Leadership from East Carolina University.
Jim Sianis, BS, PharmD, MBA
Executive Director, Business Development
Prenosis, Inc.
Jim Sianis, BS, PharmD, MBA, is an accomplished healthcare executive with experience spanning pharmaceutical, healthcare analytics, and diagnostic solutions. As Executive Director of Business Development at Prenosis, he leads the sales and commercialization of Sepsis ImmunoScoreTM, driving the adoption of innovative healthcare solutions grounded in data and real-world evidence.
During his 14-year tenure at Premier, Inc. Jim played a pivotal role in commercializing PINC AI's Healthcare Database, partnering with pharmaceutical, device, and diagnostic companies to create innovative solutions for unmet research needs. He also served at Merck as Medical Science Liaison supporting the anti-infective franchise, conducting high-level discussions with infectious disease thought leaders and supporting successful product launches. Jim worked as a clinical pharmacy specialist in infectious diseases at Lehigh Valley Hospital in Allentown, Pennsylvania, and served as a Hospital Corpsman and Pharmacy Technician in the United States Navy.
Jim combines deep clinical expertise with strong business acumen. His approach to business development is characterized by a strong commitment to integrity, collaboration, and strategic insight, enabling him to bridge the gap between healthcare innovation and commercial success.